Libre de lecture

Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors

Dolinsek, Tanja

,

,

,

Potocnik, Tjasa

et

19 juil. 2016

Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors's Cover Image

Radiology and Oncology

Édition 50 (2016): Edition 3 (Septembre 2016)

À propos de cet article

Article précédent

Article suivant

Citez

Partagez

Télécharger la couverture

Catégorie d'article: Research Article

Publié en ligne: 19 juil. 2016

Pages: 274 - 279

Reçu: 23 mai 2016

Accepté: 14 juin 2016

DOI: https://doi.org/10.1515/raon-2016-0042

Mots clés
electrochemotherapy, BRAF inhibitors, vemurafenib, melanoma

© 2016 Fazekas and Porvázsnyik, published by De Gruyter Open

This content is free.

Survival of melanoma cells after vemurafenib (VMF) treatment. Survival of (A) BRAF V600E mutated melanoma cells SK-MEL-28 and (B) non-mutated melanoma cells CHL-1.

Survival of BRAF V600E mutated SK-MEL-28 melanoma cells and non-mutated CHL-1 cells after ECT with bleomycin. BLM (bleomycin); BLM + EP (ECT with bleomycin). Dotted line represents the IC90 value.

Survival of BRAF V600E mutated SK-MEL-28 melanoma cells after concomitant treatment with ECT and vemurafenib. BLM (bleomycin); BLM + VMF (bleomycin and 0.5 pM vemurafenib); BLM + EP (ECT with bleomycin); BLM + EP + VMF (ECT with bleomycin and 0.5 pM vemurafenib). Dotted line represents the IC90 value.

Langue:: Anglais

Périodicité:: 4 fois par an
Sujets de la revue:: Médecine, Médecine clinique, Médecine interne, Hématologie, oncologie, Radiologie

RSS Feed de la revue